• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有患阿尔茨海默病遗传风险人群的血浆信号蛋白:APOE基因型的影响。

Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.

作者信息

Ringman John M, Elashoff David, Geschwind Daniel H, Welsh Brian T, Gylys Karen H, Lee Cathy, Cummings Jeffrey L, Cole Greg M

机构信息

Mary S. Easton Center for Alzheimer’s Disease Research, Department of Neurology, David Geffen School of Medicine at UCLA, 10911 Weyburn Ave, Ste 200, Los Angeles, CA 90095, USA.

出版信息

Arch Neurol. 2012 Jun;69(6):757-64. doi: 10.1001/archneurol.2012.277.

DOI:10.1001/archneurol.2012.277
PMID:22689192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3668092/
Abstract

OBJECTIVE

To study the effect of familial Alzheimer disease (FAD) mutations and APOE genotype on plasma signaling protein levels.

DESIGN

Cross-sectional comparison of plasma levels of 77 proteins measured using multiplex immune assays.

SETTING

A tertiary referral dementia research center.

PARTICIPANTS

Thirty-three persons from families harboring PSEN1 or APP mutations, aged 19 to 59 years.

MAIN OUTCOME MEASURES

Protein levels were compared between FAD mutation carriers (MCs) and noncarriers (NCs) and among APOE genotype groups, using multiple linear regression models.

RESULTS

Twenty-one participants were FAD MCs and 12 were NCs. Six had the APOE ε2/3, 6 had the ε3/4, and 21 had the ε3/3 genotype. Levels of 17 proteins differed among APOE genotype groups, and there were significant interactions between age and APOE genotype for 12 proteins. Plasma levels of apolipoprotein E and superoxide dismutase 1 were highest in the ε2 carriers, lowest in ε4 carriers, and intermediate in the ε3 carriers. Levels of multiple interleukins showed the opposite pattern and, among the ε4 carriers, demonstrated significant negative correlations with age. Although there were no significant differences between FAD MCs and NCs, there were interactions between mutation status and APOE genotype for 13 proteins.

CONCLUSIONS

We found different patterns of inflammatory markers in young and middle-aged persons among APOE genotype groups. The APOE ε4 carriers had the lowest levels of apolipoprotein E. Young ε4 carriers have increased inflammatory markers that diminish with age. We demonstrated altered inflammatory responses in young and middle adulthood in ε4 carriers that may relate to AD risk later in life.

摘要

目的

研究家族性阿尔茨海默病(FAD)突变和载脂蛋白E(APOE)基因型对血浆信号蛋白水平的影响。

设计

采用多重免疫分析法对77种蛋白质的血浆水平进行横断面比较。

地点

一家三级转诊痴呆研究中心。

参与者

来自携带早老素1(PSEN1)或淀粉样前体蛋白(APP)突变家族的33人,年龄在19至59岁之间。

主要观察指标

使用多元线性回归模型比较FAD突变携带者(MCs)和非携带者(NCs)之间以及APOE基因型组之间的蛋白质水平。

结果

21名参与者为FAD MCs,12名为NCs。6人具有APOE ε2/3基因型,6人具有ε3/4基因型,21人具有ε3/3基因型。17种蛋白质的水平在APOE基因型组之间存在差异,12种蛋白质在年龄和APOE基因型之间存在显著交互作用。ε2携带者中载脂蛋白E和超氧化物歧化酶1的血浆水平最高,ε4携带者中最低,ε3携带者中处于中间水平。多种白细胞介素的水平呈现相反的模式,在ε4携带者中,与年龄呈显著负相关。虽然FAD MCs和NCs之间没有显著差异,但13种蛋白质在突变状态和APOE基因型之间存在交互作用。

结论

我们在APOE基因型组的中青年人群中发现了不同的炎症标志物模式。APOE ε4携带者的载脂蛋白E水平最低。年轻的ε4携带者炎症标志物增加,且随年龄增长而减少。我们证明了ε4携带者在中青年期炎症反应发生改变,这可能与晚年患阿尔茨海默病的风险有关。

相似文献

1
Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.有患阿尔茨海默病遗传风险人群的血浆信号蛋白:APOE基因型的影响。
Arch Neurol. 2012 Jun;69(6):757-64. doi: 10.1001/archneurol.2012.277.
2
Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.APOE ε4和ε2对常染色体显性阿尔茨海默病患者血浆神经丝轻链及认知功能的影响
Alzheimers Res Ther. 2024 Oct 1;16(1):208. doi: 10.1186/s13195-024-01572-y.
3
Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.家族性阿尔茨海默病风险人群中的命题密度和载脂蛋白 E 基因型。
Dement Geriatr Cogn Disord. 2011;32(3):188-92. doi: 10.1159/000333023. Epub 2011 Aug 30.
4
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.
5
Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.载脂蛋白E基因型与阿尔茨海默病的性别风险因素:一项荟萃分析。
JAMA Neurol. 2017 Oct 1;74(10):1178-1189. doi: 10.1001/jamaneurol.2017.2188.
6
Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations.家族性阿尔茨海默病突变患者血浆蛋氨酸亚砜。
Dement Geriatr Cogn Disord. 2012;33(4):219-25. doi: 10.1159/000338546. Epub 2012 May 14.
7
Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.载脂蛋白E基因与早发性年龄相关性黄斑病变:社区动脉粥样硬化风险研究
Ophthalmology. 2006 Feb;113(2):255-9. doi: 10.1016/j.ophtha.2005.10.048. Epub 2006 Jan 10.
8
APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease.载脂蛋白 E ε4 对常染色体显性阿尔茨海默病的 APP 和 PSEN1 突变携带者的认知衰退有积极影响,对其有负面影响。
Eur J Neurol. 2022 Dec;29(12):3580-3589. doi: 10.1111/ene.15536. Epub 2022 Sep 11.
9
Increased CSF cortisol in AD is a function of APOE genotype.阿尔茨海默病患者脑脊液中皮质醇水平升高是载脂蛋白E基因型的一种表现。
Neurology. 2001 Apr 24;56(8):1094-8. doi: 10.1212/wnl.56.8.1094.
10
Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.载脂蛋白Eε4等位基因与阿尔茨海默病的家族聚集性。
Arch Neurol. 1998 Jun;55(6):810-6. doi: 10.1001/archneur.55.6.810.

引用本文的文献

1
APOE genotype and brain amyloid are associated with changes in the plasma proteome in elderly subjects without dementia.APOE基因分型和脑淀粉样蛋白与无痴呆症老年受试者血浆蛋白质组的变化有关。
Ann Clin Transl Neurol. 2025 Feb;12(2):366-382. doi: 10.1002/acn3.52250. Epub 2024 Dec 17.
2
Linking alcohol use to Alzheimer's disease: Interactions with aging and APOE along immune pathways.将酒精使用与阿尔茨海默病联系起来:沿免疫途径与衰老和载脂蛋白E的相互作用。
Med Res Arch. 2024 Aug;12(8). doi: 10.18103/mra.v12i8.5228. Epub 2024 Aug 31.
3
APOE ε4-associated downregulation of the IL-7/IL-7R pathway in effector memory T cells: Implications for Alzheimer's disease.载脂蛋白 E ε4 下调效应记忆 T 细胞中的白细胞介素 7/白细胞介素 7 受体通路:对阿尔茨海默病的影响。
Alzheimers Dement. 2024 Sep;20(9):6441-6455. doi: 10.1002/alz.14173. Epub 2024 Aug 11.
4
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer's disease.Thy1-ApoE4/C/EBPβ 双转基因小鼠可作为散发性阿尔茨海默病模型。
Mol Psychiatry. 2024 Oct;29(10):3040-3055. doi: 10.1038/s41380-024-02565-x. Epub 2024 Apr 24.
5
genotype and sex modulate Alzheimer's disease pathology in aged EFAD transgenic mice.基因型和性别调节老年EFAD转基因小鼠的阿尔茨海默病病理。
Front Aging Neurosci. 2023 Oct 31;15:1279343. doi: 10.3389/fnagi.2023.1279343. eCollection 2023.
6
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.小分子 TLR4 拮抗剂可减少 E4FAD 雌性小鼠的神经炎症。
Alzheimers Res Ther. 2023 Oct 19;15(1):181. doi: 10.1186/s13195-023-01330-6.
7
Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele.基于载脂蛋白 E ε4 等位基因携带状态的阿尔茨海默病表型。
Brain Pathol. 2024 Jan;34(1):e13208. doi: 10.1111/bpa.13208. Epub 2023 Aug 30.
8
White matter hyperintensities in cholinergic pathways are associated with dementia severity in e4 carriers but not in non-carriers.胆碱能通路中的白质高信号与携带ε4等位基因者的痴呆严重程度相关,而与非携带者无关。
Front Neurol. 2023 Feb 14;14:1100322. doi: 10.3389/fneur.2023.1100322. eCollection 2023.
9
Linking Diabetes to Alzheimer's Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase.将糖尿病与阿尔茨海默病联系起来:葡萄糖代谢和α-葡萄糖苷酶的潜在作用。
Curr Neuropharmacol. 2023;21(10):2036-2048. doi: 10.2174/1570159X21999221111102343.
10
< Variant and Early-Onset Alzheimer's Disease: A Scoping Review.< 变异型和早发型阿尔茨海默病:一项范围综述。
Front Aging Neurosci. 2022 Jul 22;14:860529. doi: 10.3389/fnagi.2022.860529. eCollection 2022.

本文引用的文献

1
Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.携带家族性阿尔茨海默病突变的无症状和患病个体脑脊液中的蛋白质组变化。
Arch Neurol. 2012 Jan;69(1):96-104. doi: 10.1001/archneurol.2011.642.
2
A serum protein-based algorithm for the detection of Alzheimer disease.一种基于血清蛋白的阿尔茨海默病检测算法。
Arch Neurol. 2010 Sep;67(9):1077-81. doi: 10.1001/archneurol.2010.215.
3
Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.家族性阿尔茨海默病突变携带者在新颖性编码任务中,风险基因对 BOLD 激活的影响。
Cereb Cortex. 2011 Apr;21(4):877-83. doi: 10.1093/cercor/bhq158. Epub 2010 Aug 20.
4
Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels.使用定量多重蛋白质组免疫分析板鉴定阿尔茨海默病的早期标志物。
Ann N Y Acad Sci. 2009 Oct;1180:56-67. doi: 10.1111/j.1749-6632.2009.05066.x.
5
Systemic inflammation and disease progression in Alzheimer disease.阿尔茨海默病中的全身炎症与疾病进展
Neurology. 2009 Sep 8;73(10):768-74. doi: 10.1212/WNL.0b013e3181b6bb95.
6
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.全基因组关联研究确定了CLU和CR1基因中与阿尔茨海默病相关的变异。
Nat Genet. 2009 Oct;41(10):1094-9. doi: 10.1038/ng.439. Epub 2009 Sep 6.
7
Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.阿尔茨海默病的家族史与较低的血浆载脂蛋白E水平相关。
Neurology. 2009 Sep 1;73(9):681-7. doi: 10.1212/WNL.0b013e3181b59c2e.
8
The role of apolipoprotein E in Alzheimer's disease.载脂蛋白E在阿尔茨海默病中的作用。
Neuron. 2009 Aug 13;63(3):287-303. doi: 10.1016/j.neuron.2009.06.026.
9
A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease.布洛芬对阿尔茨海默病认知进展影响的随机对照研究。
Aging Clin Exp Res. 2009 Apr;21(2):102-10. doi: 10.1007/BF03325217.
10
Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.载脂蛋白E(ApoE)基因多态性对脑内ApoE水平的影响。
J Neurosci. 2008 Nov 5;28(45):11445-53. doi: 10.1523/JNEUROSCI.1972-08.2008.